Andexanet for FXa Inhibitor-Associated Acute ICH | NEJM

Acute intracerebral hemorrhage may occur in patients on factor Xa inhibitors. The efficacy and safety of the FXa inhibitor reversal agent andexanet for limiting ICH volume expansion are unknown.
Research findings are summarized in a new Quick Take video.
To see the full article, follow this link: nej.md/3wAoERb
#neurology #hematology #emergencymedicine #clinicaltrials #nejm

[@hafizuddinabas1968]

what the hell are these endpoints? reading the paper, its not even blinded.

[@IOSARBX]

NEJM Group, You're awesome! Let's be friends and play together!